• MAR 21 2019

    Abstracts to be Presented at AACR 2019

    Oncoceutics, Inc. and its commercial and academic collaborators will be presenting multiple abstracts at the 2019 annual meeting of the American Association for Cancer Research in Atlanta, Georgia, on March 29th to April 3rd.  These abstracts will highlight ONC201’s unique mechanism of action, various single agent and combination data, and characterization of other imipridones, including

    • NOV 19 2018

    ONC201 Advocacy Meeting at SNO 2018 – New Orleans, November 17, 2018

    Advocacy Meeting – Oncoceutics, a clinical-stage drug discovery and development company. Looking forward to hearing about what's fresh and new! And who says SNO meetings aren't fun??? Check out THESE faces! 😉 #SNO2018 #endbraincancer — End Brain Cancer Initiative (@EndBrainCancer) November 17, 2018